company
Viatris, Inc.
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · drug_recall2026-04-15Viatris, Inc. — Class II recall: Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx onl…
Frequently asked questions
- How many FDA warning letters has Viatris, Inc. received?
- Argus HQ has not recorded an FDA warning letter for Viatris, Inc. in our current dataset.
- What FDA recalls has Viatris, Inc. issued?
- Argus HQ has recorded 1 FDA recall tied to Viatris, Inc..
- Is Viatris, Inc. FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 1 recall, and 0 approval records for Viatris, Inc.. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

